Clinical Trial

A Study to Evaluate the Safety, Tolerability, PK and Efficacy of Hemay5087 in Patients With Advanced Solid Tumors

Name: A Study to Evaluate the Safety, Tolerability, PK and Efficacy of Hemay5087 in Patients With Advanced Solid Tumors — clinical trial record (NCT07624864)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

An open-label phase I clinical study,which enrolled subjects with advanced solid tumors who have failed to respond to adequate standard therapies or have no available effective standard therapy.

Trial Details

NCT Number	NCT07624864
Lead Sponsor	Ganzhou Hemay Pharmaceutical Co., Ltd
Conditions	Solid Tumors
Enrollment	24 participants
Start Date	2026-07-15
Primary Completion	2028-04-30 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-03